Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Ángela Vinué"'
Autor:
Sergio Martínez-Hervás, Verónica Sánchez-García, Andrea Herrero-Cervera, Ángela Vinué, José Tomás Real, Juan F. Ascaso, Deborah Jane Burks, Herminia González-Navarro
Publikováno v:
Journal of Translational Medicine, Vol 17, Iss 1, Pp 1-12 (2019)
Abstract Background Type 1 diabetes mellitus (T1DM) patients display increased risk of cardiovascular disease (CVD) and are characterized by a diminished regulatory T (Treg) cell content or function. Previous studies have shown an association between
Externí odkaz:
https://doaj.org/article/154af6c4f651498298baf480250ce69a
Autor:
Andrea Herrero-Cervera, Carla Espinós-Estévez, Susana Martín-Vañó, Alida Taberner-Cortés, María Aguilar-Ballester, Ángela Vinué, Laura Piqueras, Sergio Martínez-Hervás, Herminia González-Navarro
Publikováno v:
Biomedicines, Vol 9, Iss 11, p 1518 (2021)
Abdominal aortic aneurysm (AAA), is a complex disorder characterized by vascular vessel wall remodeling. LIGHT (TNFSF14) is a proinflammatory cytokine associated with vascular disease. In the present study, the impact of genetic inactivation of Light
Externí odkaz:
https://doaj.org/article/f74087f9be3e4f8498c9c7cce0dd4d90
Autor:
Alida Taberner-Cortés, Ángela Vinué, Andrea Herrero-Cervera, María Aguilar-Ballester, José Tomás Real, Deborah Jane Burks, Sergio Martínez-Hervás, Herminia González-Navarro
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 23, p 9216 (2020)
Type 2 diabetes mellitus (T2DM) increases morbimortality in humans via enhanced susceptibility to cardiovascular disease (CVD). Sodium-glucose co-transporter 2 inhibitors (SGLT2i) are drugs designed for T2DM treatment to diminish hyperglycaemia by re
Externí odkaz:
https://doaj.org/article/5e6d3b0e156945548b9ef7f61292acee
Autor:
Irene Andrés-Blasco, Sebastian Blesa, Ángela Vinué, Herminia González-Navarro, José Tomás Real, Sergio Martínez-Hervás, Julián Carretero, Antonio Ferrández-Izquierdo, Felipe Javier Chaves, Ana-Bárbara García-García
Publikováno v:
Nutrients, Vol 12, Iss 10, p 3130 (2020)
Macronutrients represent risk factors for hyperlipidemia or diabetes. Lipid alterations and type 2 diabetes mellitus are global health problems. Overexpression of sterol regulatory element-binding factor (Srebf2) in transgenic animals is linked to el
Externí odkaz:
https://doaj.org/article/7d82cac72d1d4f90a10e39de404c32b3
Autor:
María Aguilar-Ballester, Andrea Herrero-Cervera, Ángela Vinué, Sergio Martínez-Hervás, Herminia González-Navarro
Publikováno v:
Nutrients, Vol 12, Iss 7, p 2021 (2020)
Cholesterol, the most important sterol in mammals, helps maintain plasma membrane fluidity and is a precursor of bile acids, oxysterols, and steroid hormones. Cholesterol in the body is obtained from the diet or can be de novo synthetized. Cholestero
Externí odkaz:
https://doaj.org/article/8d44eb347cc54dfea4de8846f3769558
Publikováno v:
Nutrients, Vol 10, Iss 7, p 939 (2018)
The development of certain chronic metabolic diseases has been attributed to elevated levels of dietary cholesterol. However, decades of research in animal models and humans have demonstrated a high complexity with respect to the impact of dietary ch
Externí odkaz:
https://doaj.org/article/881040d9937044068c75e74175a45551
Publikováno v:
Diabetologia. 62:2143-2157
Aims/hypothesis Non-alcoholic fatty liver disease (NAFLD) is frequently associated with type 2 diabetes mellitus. Progression of NAFLD is mediated, among other things, by activation of inflammatory pathways. In the present study, the role of the proi
Autor:
Herminia González-Navarro, Juan F. Ascaso, Verónica Sánchez-García, Andrea Herrero-Cervera, Ángela Vinué, Sergio Martínez-Hervás, Deborah J. Burks, José T. Real
Publikováno v:
Journal of Translational Medicine, Vol 17, Iss 1, Pp 1-12 (2019)
Martínez Hervás, Sergio Sánchez-García, Verónica Herrero-Cervera, Andrea Vinué Visús, María Ángela Real Collado, José Tomás Ascaso Gimilio, Juan Francisco Burks, Deborah Jane González Navarro, Herminia 2019 Type 1 diabetic mellitus patientswith increased atherosclerosisriskdisplay decreased CDKN2A/2B/2BAS gene expression in leukocytes Journal Of Translational Medicine 17 1 222
Journal of Translational Medicine
RODERIC. Repositorio Institucional de la Universitat de Valéncia
instname
Martínez Hervás, Sergio Sánchez-García, Verónica Herrero-Cervera, Andrea Vinué Visús, María Ángela Real Collado, José Tomás Ascaso Gimilio, Juan Francisco Burks, Deborah Jane González Navarro, Herminia 2019 Type 1 diabetic mellitus patientswith increased atherosclerosisriskdisplay decreased CDKN2A/2B/2BAS gene expression in leukocytes Journal Of Translational Medicine 17 1 222
Journal of Translational Medicine
RODERIC. Repositorio Institucional de la Universitat de Valéncia
instname
Background Type 1 diabetes mellitus (T1DM) patients display increased risk of cardiovascular disease (CVD) and are characterized by a diminished regulatory T (Treg) cell content or function. Previous studies have shown an association between decrease
Autor:
Juan Vicente Sanchez-Andres, Herminia González-Navarro, Jose Viña, Mari Carmen Gomez-Cabrera, Adrián De la Rosa, Ángela Vinué
Publikováno v:
Free radical biologymedicine. 164
NAD(P)H donates electrons for reductive biosynthesis and antioxidant defense across all forms of life. Glucose-6- phosphate dehydrogenase (G6PD) is a critical enzyme to provide NADPH. G6PD deficiency is present in more than 400 million people worldwi
Autor:
Herminia González-Navarro, Ángela Vinué, María Aguilar-Ballester, José T. Real, Andrea Herrero-Cervera, Deborah J. Burks, Alida Taberner-Cortés, Sergio Martínez-Hervás
Publikováno v:
International Journal of Molecular Sciences
International Journal of Molecular Sciences, Vol 21, Iss 9216, p 9216 (2020)
Volume 21
Issue 23
International Journal of Molecular Sciences, Vol 21, Iss 9216, p 9216 (2020)
Volume 21
Issue 23
Type 2 diabetes mellitus (T2DM) increases morbimortality in humans via enhanced susceptibility to cardiovascular disease (CVD). Sodium-glucose co-transporter 2 inhibitors (SGLT2i) are drugs designed for T2DM treatment to diminish hyperglycaemia by re